It is not normal vicissitudes. It is poor management judgement overpaying for assets.
Given they were also buying from a private equity owner, the purchase price should have been screaming caution.
- Forums
- ASX - By Stock
- Ann: ORA - FY24 Trading Update
It is not normal vicissitudes. It is poor management judgement...
Featured News
Add ORA (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.45 |
Change
-0.010(0.41%) |
Mkt cap ! $3.271B |
Open | High | Low | Value | Volume |
$2.39 | $2.47 | $2.39 | $1.233M | 506.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
17 | 41965 | $2.44 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.45 | 7016 | 16 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
19 | 25233 | 2.450 |
21 | 103110 | 2.440 |
13 | 75686 | 2.430 |
8 | 17389 | 2.420 |
4 | 11191 | 2.410 |
Price($) | Vol. | No. |
---|---|---|
2.460 | 17177 | 13 |
2.470 | 96051 | 22 |
2.480 | 75620 | 17 |
2.490 | 21821 | 10 |
2.500 | 31730 | 13 |
Last trade - 12.00pm 13/11/2024 (20 minute delay) ? |
Featured News
ORA (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online